St. Louis University School of Medicine
3691 Rutger
Suite 100
St. Louis,
MO
USA
63110-2515
Email:
belsherb@slu.edu
Biographical Sketch:
1989 – Present – Professor of Medicine, Pediatrics, and Molecular Microbiology Saint Louis University School of Medicine, St. Louis, MO
1989 – Present – Director, Division of Infectious Diseases and Immunology, Saint Louis University School of Medicine, St. Louis, MO
1995 – Present – Dianna and J. Joseph Adorjan Endowed Professor of Infectious Diseases and Immunology, Saint Louis University School of Medicine, St. Louis, MO
1986 – 1987 – Visiting Scientist, National Institute for Medical Research, Medical Research Council, Mill Hill, London, UK, June 1986 - March 1987
1984 – 1989 – Professor of Microbiology, Marshall University School of Medicine, Huntington, WV
1984 – 1985 – Acting Chairman, Department of Medicine, Marshall University School of Medicine
1980 – 1984 – Associate Professor of Microbiology, Marshall University School of Medicine, Huntington, WV
1978 – 1989 – Chief of the Section of Infectious Diseases, Marshall University School of Medicine, Huntington, WV
1983 – 1989 – Professor of Medicine, Marshall University School of Medicine, Huntington, WV
1978 – 1983 – Associate Professor of Medicine, Marshall University School of Medicine, Huntington, WV
1977 – 1978 – Medical Officer, USPHS, National Institutes of Health, NIAID, LID, Bethesda, MD
1975 – 1977 – Research Associate, USPHS, National Institutes of Health, NIAID, LID, Bethesda, MD
1975 – 1978 – United States Public Health Service
Clinical and laboratory research interests include the development of live attenuated respiratory virus vaccines, such as respiratory syncytial virus, parainfluenza, and influenza.
Organized and chaired several large pivotal efficacy trials of influenza vaccines for the NIH and industry.
Served on FDA and CDC advisory committees pertaining to vaccine regulatory matters and assisted in developing vaccine usage guidelines and recommendations.
Currently chairs the Herpevac Trial For Women, an ongoing NIAID study of HSV-2 vaccine in women.
Scholarly contributions include more than 200 publications to journals such as The New England Journal of Medicine and JAMA, as well as numerous presentations at scientific meetings.